PhenixFIN (NYSE:PFX) Stock Rating Cut to “Hold” at Zacks Research

Zacks Research lowered shares of PhenixFIN (NYSE:PFX – Free Report) from a strong-buy rating to a hold rating in a research report report published on Monday,Zacks reports.

PhenixFIN Price Performance

PFX stock opened at $44.59 on Monday. The stock has a market capitalization of $86.10 million, a PE ratio of 5.47 and a beta of 0.32. The company’s 50-day moving average is $46.72 and its 200-day moving average is $43.70. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.21 and a quick ratio of 1.21. PhenixFIN has a 1 year low of $38.30 and a 1 year high of $56.48.

Institutional Trading of PhenixFIN

An institutional investor recently bought a new position in PhenixFIN stock. Legal & General Group Plc acquired a new stake in shares of PhenixFIN Co. (NYSE:PFX – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 15,140 shares of the company’s stock, valued at approximately $655,000. Legal & General Group Plc owned 0.78% of PhenixFIN as of its most recent filing with the Securities and Exchange Commission (SEC). 43.35% of the stock is owned by institutional investors and hedge funds.

About PhenixFIN

(Get Free Report)

PhenixFIN Corporation (NYSE:PFX) is a business development company (BDC) that provides financing to privately owned, middle-market companies. The company seeks to generate income and long-term capital appreciation by investing in businesses that may have limited access to traditional sources of capital.

PhenixFIN primarily invests in senior secured loans, including first-lien and unitranche facilities, as well as second-lien and subordinated debt. It may also make equity investments and acquire other securities in connection with its financing activities.

Featured Stories

Receive News & Ratings for PhenixFIN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhenixFIN and related companies with MarketBeat.com's FREE daily email newsletter.